With regard to the IL-10, low levels of this biomarker are present in patients with T2D compared with healthy patients, which leads to a lesser control or prevention in the production of biomarkers such as the TNF- α and IL-6 [25]. This evidence concerns the gene TNF and type 2 diabetes mellitus.